Gainers
- TransCode Therapeutics (NASDAQ:RNAZ) stock moved upwards by 49.2% to $1.12 during Tuesday's after-market session. Today's trading volume for this security ended up closing at 2.8 million shares, which is 97.3 percent of its average volume over the last 100 days. The company's market cap stands at $14.5 million.
- Quoin Pharmaceuticals (NASDAQ:QNRX) stock moved upwards by 17.46% to $1.95. This security traded at a volume of 154.4K shares come close, making up 134.3% of its average volume over the last 100 days. The market value of their outstanding shares is at $9.4 million.
- Evoke Pharma (NASDAQ:EVOK) shares moved upwards by 7.42% to $4.34. The company's market cap stands at $14.5 million.
- OKYO Pharma (NASDAQ:OKYO) stock increased by 7.14% to $2.7. The market value of their outstanding shares is at $58.7 million.
- Clearside Biomedical (NASDAQ:CLSD) stock rose 6.37% to $1.5. The market value of their outstanding shares is at $90.2 million.
- MEI Pharma (NASDAQ:MEIP) stock moved upwards by 5.18% to $0.3. Today's trading volume for this security ended up closing at 114.3K shares, which is 9.0 percent of its average volume over the last 100 days. The company's market cap stands at $39.9 million.
Losers
- Poseida Therapeutics (NASDAQ:PSTX) shares fell 9.5% to $6.3 during Tuesday's after-market session. The company's market cap stands at $541.4 million.
- Taysha Gene Therapies (NASDAQ:TSHA) shares declined by 9.15% to $1.49. The market value of their outstanding shares is at $93.0 million.
- Imunon (NASDAQ:IMNN) stock declined by 6.44% to $1.5. The market value of their outstanding shares is at $11.1 million.
- SINTX Technologies (NASDAQ:SINT) stock declined by 6.15% to $8.4. The market value of their outstanding shares is at $4.3 million.
- LumiraDx (NASDAQ:LMDX) shares fell 5.95% to $0.88. The market value of their outstanding shares is at $279.5 million.
- Varex Imaging (NASDAQ:VREX) stock declined by 5.78% to $20.25. The company's market cap stands at $811.7 million. The company's, Q1 earnings came out today. See Also:
This article was generated by Benzinga's automated content engine and reviewed by an editor.